MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
- PMID: 36831285
- PMCID: PMC9954064
- DOI: 10.3390/cells12040617
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Abstract
Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous cellular signal transduction pathways that regulate all aspects of life and are frequently altered in disease. Once activated through phosphorylation, these MAPKs in turn phosphorylate and activate transcription factors present either in the cytoplasm or in the nucleus, leading to the expression of target genes and, as a consequence, they elicit various biological responses. The aim of this work is to provide a comprehensive review focusing on the roles of MAPK signaling pathways in ocular pathophysiology and the potential to influence these for the treatment of eye diseases. We summarize the current knowledge of identified MAPK-targeting compounds in the context of ocular diseases such as macular degeneration, cataract, glaucoma and keratopathy, but also in rare ocular diseases where the cell differentiation, proliferation or migration are defective. Potential therapeutic interventions are also discussed. Additionally, we discuss challenges in overcoming the reported eye toxicity of some MAPK inhibitors.
Keywords: ERK; JNK; MAPK; eye toxicity; ocular diseases; p38; therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology.J Biol Chem. 2001 Aug 3;276(31):29490-8. doi: 10.1074/jbc.M100699200. Epub 2001 May 29. J Biol Chem. 2001. PMID: 11382751
-
Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.J Pharm Pharmacol. 2015 Oct;67(10):1380-92. doi: 10.1111/jphp.12438. Epub 2015 Jun 16. J Pharm Pharmacol. 2015. PMID: 26078032
-
The activation of ERK1/2 and p38 mitogen-activated protein kinases is dynamically regulated in the developing rat visual system.Int J Dev Neurosci. 2008 May-Jun;26(3-4):355-62. doi: 10.1016/j.ijdevneu.2007.12.007. Epub 2008 Jan 6. Int J Dev Neurosci. 2008. PMID: 18280691
-
Metastasis and MAPK Pathways.Int J Mol Sci. 2022 Mar 31;23(7):3847. doi: 10.3390/ijms23073847. Int J Mol Sci. 2022. PMID: 35409206 Free PMC article. Review.
-
The role of mitogen-activated protein kinase pathways in Alzheimer's disease.Neurosignals. 2002 Sep-Oct;11(5):270-81. doi: 10.1159/000067426. Neurosignals. 2002. PMID: 12566928 Review.
Cited by
-
P38 MAPK Signaling in the Retina: Effects of Aging and Age-Related Macular Degeneration.Int J Mol Sci. 2023 Jul 18;24(14):11586. doi: 10.3390/ijms241411586. Int J Mol Sci. 2023. PMID: 37511345 Free PMC article.
-
Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy.J Transl Med. 2025 Mar 26;23(1):374. doi: 10.1186/s12967-025-06391-9. J Transl Med. 2025. PMID: 40140939 Free PMC article.
-
The role of ERK1/2 signaling in diabetes: pathogenic and therapeutic implications.Front Pharmacol. 2025 May 9;16:1600251. doi: 10.3389/fphar.2025.1600251. eCollection 2025. Front Pharmacol. 2025. PMID: 40417223 Free PMC article. Review.
-
ERK1/2 gene expression and hypomethylation of Alu and LINE1 elements in patients with type 2 diabetes with and without cataract: Impact of hyperglycemia-induced oxidative stress.J Diabetes Investig. 2025 Apr;16(4):689-706. doi: 10.1111/jdi.14405. Epub 2025 Jan 13. J Diabetes Investig. 2025. PMID: 39804191 Free PMC article.
-
Gene expression study in the siRNA based aniridia cell model and in primary aniridia limbal epithelial cells following duloxetine and ritanserin treatment.PLoS One. 2025 Jun 10;20(6):e0324829. doi: 10.1371/journal.pone.0324829. eCollection 2025. PLoS One. 2025. PMID: 40493651 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous